Category: Pharmaceutical Technology
Explore the future of generic combinations, including regulatory hurdles, market growth projections, and therapeutic trends shaping the pharmaceutical industry through 2035.
Discover how supply chain security protects legitimate drugs from counterfeits using serialization, DSCSA regulations, and digital tracking technologies.
Discover how long FDA generic drug approvals actually take in 2026. With median times dropping to ~25 days, learn about GDUFA goals, AI impacts, and why complex drugs still face delays.
Discover how the FDA monitors drugs entering the US through its five-phase import inspection process. Learn about risk-based targeting, the end of de minimis exemptions, and how to avoid shipment detention.
Discover why effective patent life is shorter than the standard 20-year term. Learn how R&D timelines, the Hatch-Waxman Act, and evergreening strategies impact drug market exclusivity and generic competition.
Explore the complex challenges of proving bioequivalence for combination products, from FDC interactions to drug-device user interface hurdles and regulatory traps.
Explore how blockchain technology is eliminating counterfeit medicines and securing the generic drug supply chain through immutable digital pedigrees and DSCSA compliance.